VRX.TO - Valeant Pharmaceuticals International, Inc.

Toronto - Toronto Delayed Price. Currency in CAD
Currency in CAD
Earnings EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts1141315
Avg. Estimate0.950.573.83.53
Low Estimate0.810.473.612.89
High Estimate1.280.714.144.57
Year Ago EPS1.260.785.473.8
Revenue EstimateCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
No. of Analysts1141416
Avg. Estimate2.15B1.94B8.71B8.38B
Low Estimate2.06B1.87B8.61B7.96B
High Estimate2.23B2.03B8.79B8.77B
Year Ago Sales2.4B2.11B9.67B8.71B
Sales Growth (year/est)-10.60%-8.20%-9.90%-3.80%
Earnings History12/30/20163/30/20176/29/20179/29/2017
EPS Est.1.20.820.940.88
EPS Actual1.260.781.031.04
Difference0.06-0.040.090.16
Surprise %5.00%-4.90%9.60%18.20%
EPS TrendCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Current Estimate0.950.573.83.53
7 Days Ago0.930.573.773.49
30 Days Ago0.930.573.773.49
60 Days Ago0.940.63.663.45
90 Days Ago0.950.623.673.47
EPS RevisionsCurrent Qtr. (Dec 2017)Next Qtr. (Mar 2018)Current Year (2017)Next Year (2018)
Up Last 7 Days1N/A11
Up Last 30 Days1N/A11
Down Last 30 DaysN/AN/AN/AN/A
Down Last 90 DaysN/AN/AN/AN/A
Growth EstimatesVRX.TOIndustrySectorS&P 500
Current Qtr.-24.60%N/AN/A0.23
Next Qtr.-26.90%N/AN/A0.26
Current Year-30.50%N/AN/A0.08
Next Year-7.10%N/AN/A0.12
Next 5 Years (per annum)-12.90%N/AN/A0.10
Past 5 Years (per annum)-4.41%N/AN/AN/A